The comparison of effectivity in breast cancer prevention between skin sparing and subcutaneous mastectomy – 20 years of experience

1. Giaquinto AN., Sung H., Miller KD., et al. Breast cancer statistics 2022. CA Cancer J Clin. 2022, 72 (6): 524–541.

2. World Health Organization. WHOQOL –⁠ measuring quality of life. [online]. Available from: https: //www.who.int/tools/whoqol#: ~: text=WHO%20defines%20Quality%20of%20Life,%2C%20expectations%2C%20standards%20and%20concerns.

3. Kwan ML., Ergas IJ., Somkin CP., et al. Quality of life among women recently diagnosed with invasive breast cancer: the pathways study. Breast Cancer Res Treat. 2010, 123 (2): 507–524.

4. Park JH., Jung YS., Kim JY., et al. Determinants of quality of life in women immediately following the completion of primary treatment of breast cancer: a cross-sectional study. PLoS One. 2021, 16 (10): e0258447.

5. Duffy SW., Tabár L., Yen AM., et al. Mammography screening reduces rates of advanced and fatal breast cancers: results in 549,091 women. Cancer. 2020, 126 (13): 2971–2979.

6. Kluger J., Park A. The Angelina effect. Time. 2013, 181 (20): 28–33.

7. Casaubon JT., Kashyap S., Regan JP. BRCA1 and BRCA2 mutations. In: StatPearls [online]. Treasure Island (FL): StatPearls Publishing; 2023.

8. Ochs-Balcom HM., Marian C., Nie J., et al. Adiposity is associated with P53 gene mutations in breast cancer. Breast Cancer Res Treat. 2015, 153 (3): 635–645.

10. Ginsburg O., Bray F., Coleman MP., et al. The global burden of women’s cancers: a grand challenge in global health. Lancet. 2017, 389 (10071): 847–860.

11. Horton CE., Dascombe WH. Total mastectomy: indications and techniques. Clin Plast Surg. 1988, 15 (4): 677–87.

12. Cunnick GH., Mokbel K. Skin-sparing mastectomy. Am J Surg. 2004, 188 (1): 78–84.

13. Hinton CP., Doyle PJ., Blamey RW., et al. Subcutaneous mastectomy for primary operable breast cancer. Br J Surg. 1984, 71 (6): 469–472.

14. Lanitis S., Tekkis PP., Sgourakis G., et al. Comparison of skin-sparing mastectomy versus non-skin-sparing mastectomy for breast cancer. Ann Surg. 2010, 251 (4): 632–639.

15. Goldman L., Goldwyn R. Some anatomical considerations of subcutaneous mastectomy. Plast Reconstr Surg. 1973, 51 (5): 501–505.

16. de la Peña-Salcedo JA., Soto-Miranda MA., Lopez-Salguero JF. Prophylactic mastectomy: is it worth it? Aesthetic Plast Surg. 2011, 36 (1): 140–148.

17. Lostumbo L., Carbine NE., Wallace J. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev. 2010, 11: CD002748.

18. Coleman C. Early detection and screening for breast cancer. Semin Oncol Nurs. 2017, 33 (2): 141–155.

19. Berg WA. Reducing unnecessary biopsy and follow-up of benign cystic breast lesions. Radiology. 2020, 295 (1): 52–53.

20. Okano M., Nomizu T., Tachibana K., et al. The relationship between BRCA-associated breast cancer and age factors: an analysis of the japanese HBOC consortium database. J Hum Genet. 2020, 66 (3): 307–314.

21. Coltman CE., Steele JR., McGhee DE. Breast volume is affected by body mass index but not age. Ergonomics. 2017, 60 (11): 1576–1585.

22. Wang F., Alvarado M., Ewing C., et al. The impact of breast mass on outcomes of total skin-sparing mastectomy and immediate tissue expander–based breast reconstruction. Plast Reconstr Surg. 2015, 135 (3): 672–679.

23. Tousimis E., Haslinger M. Overview of indications for nipple sparing mastectomy. Gland Surg. 2018, 7 (3): 288–300.

24. Sacchini V., Pinotti JA., Barros AC., et al. Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem? J Am Coll Surg. 2006, 203 : 704–714.

25. Vila J., Gandini S., Gentilini O. Overall survival according to type of surgery in young (≤40 years) early breast cancer patients: a systematic meta-analysis comparing breast-conserving surgery versus mastectomy. Breast. 2015, 24 (3): 175–181.

26. Wu ZY., Kim HJ., Lee JW., et al. Oncologic out-comes of nipple-sparing mastectomy and immediate reconstruction after neoadjuvant chemotherapy for breast cancer. Ann Surg. 2021, 274 (6): e1196–e1201.

27. Piper ML., Rios-Diaz AJ., Kimia R., et al. Direct-to-implant versus 2-stage breast reconstruction. Ann Plast Surg. 2022, 89 (2): 159–165.

28. Jeon HB., Lee M., Roh TS., et al. Complications including capsular contracture in direct-to-implant breast reconstruction with textured anatomical versus smooth round implants: a single center retrospective analysis. J Breast Cancer. 2023, 26 (1): 25.

29. Margulies IG., Salzberg CA. The use of acellular dermal matrix in breast reconstruction: evolution of techniques over 2 decades. Gland Surg. 2019, 8 (1): 3–10.

30. Flinter F. Medical genetics: advances in brief: estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. J Medical Genetics. 1996, 33 (3): 260.

31. Kuchenbaecker KB., Hopper JL., Barnes DR., et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017, 317 (23): 2402–2416.

32. Rebbeck TR., Friebel T., Lynch HT., et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: The Prose Study Group. J Clin Oncol 2004, 22 (6): 1055–1062.

33. Cao D., Tsangaris TN., Kouprina N., et al. The superficial margin of the skin-sparing mastectomy for breast carcinoma: factors predicting involvement and efficacy of additional margin sampling. Ann Surg Oncol. 2008, 15 (5): 1330–1340.

Libor Streit, MD, PhD
Department of Plastic and Aesthetic Surgery
Faculty of Medicine, Masaryk University
Berkova 34
612 00 Brno
Czech Republic
e-mail: libor.streit@med.muni.cz

Submitted: 22. 5. 2023
Accepted: 4. 1. 2024